# Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease

> **NCT02789592** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- REM Sleep Behavior Disorder
- Parkinson Disease

## Interventions

- **DRUG:** Melatonin PR
- **DRUG:** Clonazepam
- **DRUG:** Melatonin PR placebo
- **DRUG:** Clonazepam placebo

## Key facts

- **NCT ID:** NCT02789592
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789592, "Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02789592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*